Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 1 Patrick D. Guinan, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505. Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 2 Malika Haque, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505. Case and Commentary May 2005 End of Life and Sanctity of Life, Commentary 3 Lerwut Wongsarnpigoon, MD Virtual Mentor. 2005;7(5):342-351. doi: 10.1001/virtualmentor.2005.7.5.ccas2-0505. Case and Commentary Sep 2007 Assisted Reproduction and Primum Non Nocere Marta Kolthoff, MD Virtual Mentor. 2007;9(9):605-610. doi: 10.1001/virtualmentor.2007.9.9.ccas2-0709. Case and Commentary Jun 2007 Sex Selection for Nonmedical Reasons Louise P. King, MD, JD Virtual Mentor. 2007;9(6):418-422. doi: 10.1001/virtualmentor.2007.9.6.ccas3-0706. Case and Commentary Oct 2009 The Patient Who Says He Is Ready to Die Margaret Tarpley, MLS and John Tarpley, MD Virtual Mentor. 2009;11(10):761-765. doi: 10.1001/virtualmentor.2009.11.10.ccas3-0910. Medicine and Society Feb 2009 The Double Helix and Double-Edged Sword: How the Public Thinks about Genes Jason Schnittker, PhD Virtual Mentor. 2009;11(2):155-160. doi: 10.1001/virtualmentor.2009.11.2.msoc1-0902. Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 1 Patrick D. Guinan, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 2 Malika Haque, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505.
Case and Commentary May 2005 End of Life and Sanctity of Life, Commentary 3 Lerwut Wongsarnpigoon, MD Virtual Mentor. 2005;7(5):342-351. doi: 10.1001/virtualmentor.2005.7.5.ccas2-0505.
Case and Commentary Sep 2007 Assisted Reproduction and Primum Non Nocere Marta Kolthoff, MD Virtual Mentor. 2007;9(9):605-610. doi: 10.1001/virtualmentor.2007.9.9.ccas2-0709.
Case and Commentary Jun 2007 Sex Selection for Nonmedical Reasons Louise P. King, MD, JD Virtual Mentor. 2007;9(6):418-422. doi: 10.1001/virtualmentor.2007.9.6.ccas3-0706.
Case and Commentary Oct 2009 The Patient Who Says He Is Ready to Die Margaret Tarpley, MLS and John Tarpley, MD Virtual Mentor. 2009;11(10):761-765. doi: 10.1001/virtualmentor.2009.11.10.ccas3-0910.
Medicine and Society Feb 2009 The Double Helix and Double-Edged Sword: How the Public Thinks about Genes Jason Schnittker, PhD Virtual Mentor. 2009;11(2):155-160. doi: 10.1001/virtualmentor.2009.11.2.msoc1-0902.
Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404.